|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $25,595,005 | $27,112,104 | $36,429,174 | $38,811,050 | $32,666,194 | $25,916,808 | $28,267,187 |
| Streptomycins & their derivs.; salts thereof | $1,696,123 | $1,185,141 | $1,730,880 | $2,135,876 | $1,717,934 | $1,282,332 | $1,835,551 |
| Tetracyclines & their derivs.; salts thereof | $4,858,279 | $4,076,296 | $5,121,964 | $5,051,437 | $2,587,119 | $3,816,693 | $7,078,600 |
| Chloramphenicol & its derivs.; salts thereof | $2,934,079 | $3,079,358 | $3,353,324 | $4,344,421 | $4,867,498 | $5,338,423 | $6,525,893 |
| Erythromycin & its derivs.; salts thereof | $4,582,254 | $7,582,388 | $5,795,548 | $7,727,293 | $7,210,685 | $8,565,222 | $11,418,223 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $137,578,654 | $144,088,521 | $161,334,517 | $159,054,801 | $175,315,369 | $194,139,328 | $164,045,489 |
| Total | $177,244,394 | $187,123,808 | $213,765,407 | $217,124,878 | $224,364,799 | $239,058,806 | $219,170,943 |
|
|
